No abstract available
MeSH terms
-
Animals
-
Antiviral Agents / adverse effects
-
Antiviral Agents / supply & distribution
-
Antiviral Agents / therapeutic use*
-
Betacoronavirus / drug effects*
-
Betacoronavirus / pathogenicity
-
COVID-19
-
COVID-19 Drug Treatment
-
Cardiotoxicity
-
Cardiovascular Diseases / chemically induced
-
Clinical Trials as Topic*
-
Coronavirus Infections / diagnosis
-
Coronavirus Infections / drug therapy*
-
Coronavirus Infections / virology
-
Evidence-Based Medicine*
-
Health Services Accessibility
-
Humans
-
Hydroxychloroquine / adverse effects
-
Hydroxychloroquine / supply & distribution
-
Hydroxychloroquine / therapeutic use*
-
Pandemics
-
Patient Safety
-
Pneumonia, Viral / diagnosis
-
Pneumonia, Viral / drug therapy*
-
Pneumonia, Viral / virology
-
Research Design
-
Risk Assessment
-
Risk Factors
-
SARS-CoV-2
-
Treatment Outcome
Substances
-
Antiviral Agents
-
Hydroxychloroquine